Marlise R Luskin Selected Research

Marlise R Luskin Research Topics

11	Neoplasms (Cancer) 04/2022 - 09/2015
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 03/2016
6	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 07/2015
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 08/2017
3	Viremia 04/2008 - 12/2006
2	Osteonecrosis (Kienbock's Disease) 11/2022 - 01/2022
2	Leukemia 01/2022 - 12/2015
2	Lymphoma (Lymphomas) 01/2016 - 04/2014
1	Hemorrhage 10/2022
1	Disseminated Intravascular Coagulation 10/2022
1	Vision Disorders (Hemeralopia) 10/2022
1	Philadelphia Chromosome 04/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022
1	Eosinophilia 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Essential Thrombocythemia 01/2022
1	Polycythemia Vera 01/2022
1	Carcinogenesis 01/2022
1	Mycoses (Diseases, Fungus) 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2020
1	Aneuploidy (Aneuploid) 08/2017
1	Chromosome Aberrations (Chromosome Abnormalities) 08/2017
1	Genomic Instability 01/2017
1	Second Primary Neoplasms (Neoplasms, Second) 09/2015
1	Lung Diseases (Lung Disease) 09/2015
1	Infertility (Sterility) 09/2015
1	Genetic Predisposition to Disease (Genetic Predisposition) 09/2015
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2015
1	Infections 04/2008
1	Human Influenza (Influenza) 03/2007
1	Immune Reconstitution Inflammatory Syndrome 12/2006

2	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2019
2	Interferon Type IIBA 04/2008 - 12/2006
2	CytokinesIBA 03/2007 - 12/2006
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022
1	Asparaginase (Elspar)FDA Link 11/2022
1	Retinaldehyde (Retinal)IBA 10/2022
1	Dacarbazine (DIC)FDA LinkGeneric 10/2022
1	Tyrosine Kinase InhibitorsIBA 04/2022
1	GlucocorticoidsIBA 01/2022
1	ChromatinIBA 01/2022
1	Core Binding Factors (Core-Binding Factor)IBA 01/2022
1	Inotuzumab OzogamicinIBA 01/2022
1	Imatinib Mesylate (Gleevec)FDA Link 01/2022
1	venetoclaxIBA 01/2022
1	Polycomb Repressive Complex 2IBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	gilteritinibIBA 01/2021
1	TriazolesIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 08/2019
1	Biological ProductsIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	midostaurinIBA 12/2017
1	Cell-Free Nucleic AcidsIBA 08/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	CytosineIBA 01/2017
1	Daunorubicin (Cerubidine)FDA LinkGeneric 03/2016
1	nelarabine (506U78)FDA Link 01/2016
1	Etoposide (VP 16)FDA LinkGeneric 01/2016
1	Ribavirin (Virazole)FDA LinkGeneric 04/2008
1	Interferon-alpha2bIBA 04/2008
1	Interferon-alpha (Interferon Alfa)IBA 04/2008
1	Interferon-gamma (Interferon, gamma)IBA 03/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2007
1	HIV AntigensIBA 03/2007
1	Interleukin-2 (IL2)IBA 03/2007
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 03/2007
1	LipopolysaccharidesIBA 12/2006

9	Therapeutics 01/2022 - 12/2006
4	Drug Therapy (Chemotherapy) 04/2022 - 09/2015
4	Hematopoietic Stem Cell Transplantation 11/2016 - 07/2015
3	Cell Transplantation 01/2021 - 01/2017
2	Aftercare (After-Treatment) 04/2022 - 01/2021
2	Transplantation 01/2022 - 11/2016
2	Stem Cell Transplantation 11/2016 - 02/2015
1	Induction Chemotherapy 10/2022
1	Music Therapy 04/2022